Early-onset colorectal cancer is associated with markedly increased tissue stiffness and fibrosis, suggesting a distinct ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

There are two trials that I think are probably the most excited about. One of them is called the PEAK trial, and it was a ...

Boca Raton, FL, Dec. 05, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, announces a recently published ...

GISTs are a rare type of cancer that develops in the digestive tract’s connective tissue, specifically from cells that help regulate muscle contractions. GISTs are primarily driven by genetic ...

Getting the right nutrition can be challenging when you’re living with advanced gastrointestinal stromal tumors, also known as GIST. GIST usually requires surgeries to remove tumors and certain ...

The ORR was 70% in patients treated with remestemcel-L, with 30% having a complete response and 41% having a partial response. The Food and Drug Administration (FDA) has approved Ryoncil ® ...

Stem cell therapy, in which stem cells are used for disease treatment or tissue repair, is an increasingly active area of research. Treatment of many chronic diseases with mesenchymal stromal cells ...